Ricarda M. Hoffmann

1.1k total citations
6 papers, 257 citations indexed

About

Ricarda M. Hoffmann is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ricarda M. Hoffmann has authored 6 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Ricarda M. Hoffmann's work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (2 papers). Ricarda M. Hoffmann is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (2 papers). Ricarda M. Hoffmann collaborates with scholars based in United Kingdom and Italy. Ricarda M. Hoffmann's co-authors include Sophia N. Karagiannis, Silvia Mele, Anthony Cheung, James Spicer, Silvia Crescioli, Debra H. Josephs, Kristina M. Ilieva, David E. Thurston, Ben G T Coumbe and Andrew Tutt and has published in prestigious journals such as Cancer Research, Scientific Reports and Oncotarget.

In The Last Decade

Ricarda M. Hoffmann

5 papers receiving 247 citations

Peers

Ricarda M. Hoffmann

ONCOL

RNMI

MB

IMMUN

PRM

Ute Jucknischke Switzerland

Jens Wuerthner United States

Irene Manrique Spain

Eric Haines United States

Mary Jane Hinrichs United States

Gabriela Cinat Argentina

Christa L. Borgman United States

Franck Dubin France

Cristina Chiriaco Italy

Philippe Giron Belgium

Ute Jucknischke Switzerland

Ricarda M. Hoffmann

72 ×0.4

ONCOL

68 ×0.6

RNMI

139 ×1.3

MB

27 ×0.6

IMMUN

24 ×1.0

PRM

Citations per year, relative to Ricarda M. Hoffmann Ricarda M. Hoffmann (= 1×) peers Ute Jucknischke

Countries citing papers authored by Ricarda M. Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Ricarda M. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricarda M. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricarda M. Hoffmann more than expected).

Fields of papers citing papers by Ricarda M. Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricarda M. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricarda M. Hoffmann. The network helps show where Ricarda M. Hoffmann may publish in the future.

Co-authorship network of co-authors of Ricarda M. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ricarda M. Hoffmann. A scholar is included among the top collaborators of Ricarda M. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricarda M. Hoffmann. Ricarda M. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Cheung, Anthony, Alicia M. Chenoweth, Jelmar Quist, et al.. (2022). CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models. Cancers. 14(14). 3361–3361. 11 indexed citations

2.

Hoffmann, Ricarda M., Silvia Mele, Anthony Cheung, et al.. (2020). Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs). Scientific Reports. 10(1). 8869–8869. 15 indexed citations

3.

Hoffmann, Ricarda M., Silvia Crescioli, Silvia Mele, et al.. (2020). A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma. Cancers. 12(4). 1029–1029. 22 indexed citations

4.

Hoffmann, Ricarda M., Silvia Crescioli, David E. Thurston, & Sophia N. Karagiannis. (2018). Abstract LB-001: Development and evaluation of T-Zap: a novel antibody-drug conjugate for the treatment of Her2 positive breast cancer. Cancer Research. 78(13_Supplement). LB–1. 1 indexed citations

5.

Hoffmann, Ricarda M., Ben G T Coumbe, Debra H. Josephs, et al.. (2017). Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs). OncoImmunology. 7(3). e1395127–e1395127. 135 indexed citations

6.

Josephs, Debra H., Silvia Mele, Silvia Crescioli, et al.. (2017). BRAF inhibitors: resistance and the promise of combination treatments for melanoma. Oncotarget. 8(44). 78174–78192. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact